First-in-Class Lupus Drug Aces Phase III Test

By News Health
2 months Ago

(MedPage Today) — BARCELONA — A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory systemic lupus erythematosus (SLE) get symptoms under control, according to phase III trial data…

Source link : https://www.medpagetoday.com/meetingcoverage/eular/116036

Author :

Publish date : 2025-06-12 16:13:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

States Sue Trump, Say Targeting of Hospitals Over Gender Care in Minors Is Unlawful

When Medicine Meets Philosophy: A New SEC Series

Alzheimer's Benefits Continue With Donanemab for 3 Years, Long-Term Data Show

Sweetener May Weaken Cancer Therapy; Hulk Hogan's CLL; Top Cancer Hospitals

Ozzy Osbourne Shined a Light on Parkinson’s Stigma

The way we train AIs makes them more likely to spout bull